Cadrenal Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Cadrenal Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2022 to Q3 2024.
  • Cadrenal Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -2.18 USD/shares, a 116% decline year-over-year.
  • Cadrenal Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.47 USD/shares, a 33.5% increase year-over-year.
  • Cadrenal Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.62 USD/shares, a 27.1% increase from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1 -$2 -$1 -116% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $0 $0 $0 -66.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $0 $0 +$0.38 +79.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$1 $0.96 +$1.59 Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 -$2 -$1 -$1 -677% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$1 $0 $0 -28.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$1 $0 $0 -2300% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$1 -$1 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $0 Jan 25, 2022 Mar 31, 2022 10-Q 2023-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.